EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Evolving strategies in cardiovascular disease prevention: 2025 American society for preventive cardiology highlights

Annalisa Filtz, Michael D Shapiro, Paul K Whelton, Ann Marie Navar, Fatima Rodriguez, Seth S Martin, Martha Gulati, Ron Blankstein, Paul M Ridker, Deepak L Bhatt, Clyde W Yancy, David J Maron und 1 weitere

American Journal of Preventive Cardiology · 2025-12 · 24 · 101357

DOI: 10.1016/j.ajpc.2025.101357 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Preventive Cardiology, 2025-12. Verfasst von Annalisa Filtz und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Division, Montefiore Health System/Albert Einstein College of Medicine, Bronx, NY, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 2025 American Society for Preventive Cardiology meeting highlighted evolving strategies in cardiovascular disease prevention, spanning risk models based on traditional risk factors, emerging biomarkers, novel therapeutics, and digital health innovations. Key discussions addressed lipoprotein(a) [Lp(a)] and inflammation as a causal risk factor, their clinical management, and readiness for targeted therapies; optimal systolic blood pressure targets informed by recent randomized controlled trials; and ongoing debate regarding apolipoprotein B versus low-density lipoprotein cholesterol (LDL-C) as the primary lipid target. Advances in digital health emphasized prevention through artificial intelligence, health equity in technology, and the growing role of wearables. Imaging emerged as a central theme, with sessions highlighting its role in risk assessment, monitoring treatment response, and refining prevention strategies, especially in young adults. Sessions on women's cardiovascular health underscored female-specific risk enhancers and limitations of current risk prediction models. Additional debates addressed the use of polygenic risk scores in young adults and strategies for universal screening with LDL-C, hsCRP, and Lp(a). Heart failure prevention was highlighted as a critical frontier, with emphasis on stage-based risk stratification, early identification of subclinical disease, and targeted interventions to avert progression to symptomatic heart failure. Updates on renal denervation reaffirmed its safety, efficacy, and durability as an adjunctive therapy in resistant hypertension. Collectively, these highlights emphasize the rapid evolution of preventive cardiology, integrating precision risk stratification, digital tools, and novel therapies into routine care.

Schlagwörter

Stichwörter der Autor:innen

American society for preventive cardiologyCardiovascular disease preventionHypertension, Cardiovascular risk factorsLipoprotein(a)Women’s health

Autor:innen und Institutionen

  • Cardiology Division, Montefiore Health System/Albert Einstein College of Medicine, Bronx, NY, USA.
  • Center for Prevention of Cardiovascular Disease, Department of Cardiovascular Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
  • Tulane University Celia Weatherhead School of Public Health and Tropical Medicine, New Orleans, Louisiana, USA.
  • Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Division of Cardiovascular Medicine and the Cardiovascular Institute, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Division of Cardiology, Department of Medicine, Johns Hopkins School of Medicine, Carnegie 591, Johns Hopkins Hospital, Baltimore, MD, USA.

Zitieren

APA

Filtz, A., Shapiro, M. D., Whelton, P. K., Navar, A. M., Rodriguez, F., Martin, S. S., Gulati, M., Blankstein, R., Ridker, P. M., Bhatt, D. L., Yancy, C. W., Maron, D. J., & Slipczuk, L. (2025). Evolving strategies in cardiovascular disease prevention: 2025 American society for preventive cardiology highlights. American Journal of Preventive Cardiology, 24, 101357. https://doi.org/10.1016/j.ajpc.2025.101357

Vancouver

Filtz A, Shapiro MD, Whelton PK, Navar AM, Rodriguez F, Martin SS, et al. Evolving strategies in cardiovascular disease prevention: 2025 American society for preventive cardiology highlights. American Journal of Preventive Cardiology. 2025;24:101357. doi:10.1016/j.ajpc.2025.101357

BibTeX
@article{Filtz2025,
  author = {Filtz, Annalisa and Shapiro, Michael D and Whelton, Paul K and Navar, Ann Marie and Rodriguez, Fatima and Martin, Seth S and Gulati, Martha and Blankstein, Ron and Ridker, Paul M and Bhatt, Deepak L and Yancy, Clyde W and Maron, David J and Slipczuk, Leandro},
  title = {Evolving strategies in cardiovascular disease prevention: 2025 American society for preventive cardiology highlights},
  journal = {American Journal of Preventive Cardiology},
  year = {2025},
  volume = {24},
  pages = {101357},
  doi = {10.1016/j.ajpc.2025.101357}
}
Kostenlos starten →